-
The danger in believing it ‘won’t happen here’
Linda Popky Business Management, Services & Risk ManagementAn enemy like the COVID-19 pandemic recognizes no borders. Yet, the spread of the virus is not occurring at an even level from country to country, or even from state to state in the U.S. While some areas made aggressive, proactive moves, others have been slow to react. I call this phenomenon Won’t Happen Here (WHH) Syndrome. WHH is not limited to pandemics. We see this kind of reaction to natural disasters (including wildfires, hurricanes, or flood), to political unrest, and even to changes in technology or market conditions.
-
How technology can help prevent workplace injuries
Terri Williams Business Management, Services & Risk ManagementA few months ago, we reported on workplace fatalities being at their highest levels since 2008, although workplace injuries are trending down. And now, the National Security Council recently released its first Work to Zero research report, "Safety Technology 2020: Mapping Technology Solutions for Reducing Serious Injuries and Fatalities in the Workplace." The report identifies the most relevant workplace hazards, along with technologies that can help to mitigate the risks.
-
Infographic: The social impact of mixing business and medicine
Brian Wallace Medical & Allied HealthcareThough the United States has one of the most expensive healthcare systems in the world, it is far from achieving the best outcomes in the world. This infographic outlines the hidden impact of mixing business with medicine, as evidenced by the drastic shortage of PPE and other necessities in the wake of COVID-19.
-
Federal surveillance, track-and-trace technology may be on the way for…
Scott E. Rupp Medical & Allied HealthcarePortions of the U.S. — those areas with the most cases of the virus — are seeing their health systems become overwhelmed. Among the carnage, former top government healthcare officials Scott Gottlieb and Farzad Mostashari are proposing the construction of a national COVID-19 surveillance system. Such a system, they said in a recent policy paper, calls for the implementations of tools and policies "to conduct more effective surveillance, containment, and case management of COVID-19 for the future."
-
Thinking critically about COVID-19, public health, and our erratic response
Keith Carlson Medical & Allied HealthcareIn these days of the COVID-19 pandemic, there is a great deal of commonly held focus on hobbled supply chains, widespread lack of PPE, the egregiously defunded American public health system, and other ills that negatively impact our ability to mitigate and respond to this existential crisis. While this writer in no way claims to have deep knowledge of healthcare economics and related policy, the obvious fact is that something is wrong when a country largely perceived to be a "global superpower" cannot effectively launch and sustain a concerted, cohesive response to such a threat. Something is indeed amiss, so how can we think critically about this lamentable turn of events?
-
Treating COVID-19-related respiratory failure with an anticoagulant: A…
Dorothy L. Tengler Medical & Allied HealthcareAs the novel coronavirus enters lung cells, it starts to replicate, destroying the cells, resulting in the most common complication of COVID-19, acute respiratory distress syndrome (ARDS). Because of this complication, ventilators have become the single most important piece of equipment in the fight to sustain these patients. A compassionate use trial is currently enrolling COVID-19 patients with ARDS to evaluate both inhaled and intravenous treatment with a common anti-clotting drug approved by the Food and Drug Administration (FDA) for treating ischemic thrombotic stroke. Researchers have long considered anticoagulants to reduce ARDS-induced death, but the treatment was never adopted or formally approved by the FDA.
-
Podcast: How to setup and market telehealth services in less than 48 hours
Jarod Carter Healthcare AdministrationIn this podcast, listen in as I give a detailed class on getting started with telehealth services as quickly as possible. This is a must-listen if you’re interested in using telehealth to get your practice through the coronavirus crisis. This episode is taken from a Q&A coaching call on telehealth services with my Mastermind group.
-
Chief Elusive Officer: 21% of non-managers have never met their CEO
Terri Williams Business Management, Services & Risk ManagementThe Chief Executive Officer (CEO) is usually the most visible person in the organization and is responsible for not only setting strategy and direction, but also for setting and modeling the company's culture. However, it may be hard to rally the troops and set an example when some of the troops don't see the person in charge. According to a recent report by Unit4, a people-based ERP software provider, 21% of employees in non-managerial positions have never met their CEO. Is this a problem, and if so, why?
-
Americans are concerned they can’t afford coronavirus care
Scott E. Rupp Medical & Allied HealthcareDuring the coronavirus crisis, Americans have plenty of fears about the virus and their health and well-being, a new Kaiser Family Foundation survey says. In it, 39% of those who responded also said they are facing financial strife and that they had either lost a job or some income because of the virus. While there are efforts in place to protect citizens financially, patients' fears about being able to afford care because of a lack of financial means may not be unfounded.
-
Urine tests can predict transplanted kidney rejection
Chelsea Adams Medical & Allied HealthcareTwo new methodologies offer promise in predicting kidney failure using a simple urine test instead of a biopsy. University of California, San Francisco researchers say a urine test they have developed would eliminate the need for an invasive biopsy to determine the chances of organ rejection. What's more, monitoring kidney health with a urine sample makes it much easier to identify a problem before the organ suffers irreparable damage. The findings appeared in the March 18 issue of Science Translational Medicine.
All Healthcare Administration Articles